samedan logo
 
 
spacer
home > pmps > spring 2003 > assuring authenticity... an issue of global importance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Assuring Authenticity... An Issue of Global Importance

Features In Substrates

Over the past 10 years the world has seen unprecedented economic growth and opportunity. In today's environment, globalisation, competition and consumer power have changed the way businesses compete and governments govern. However, these same drivers have also created a thriving business in the counterfeiting, alteration and piracy of branded products and valuable printed documents.

Document fraud threatens businesses large and small in the form of altered purchase orders, bills of lading, phoney invoices, prescriptions and coupons. For example, one-third of all promotional coupons redeemed in the US are false.

Furthermore, the increasing global demand for branded products has created a growing business in product counterfeiting, piracy and diversion. Worldwide, counterfeiting and piracy alone costs brand-owners over US$720 billion annually. The International Anti-Counterfeiting Coalition estimates that as much as eight per cent of international trade involves counterfeit goods - and the trend is growing.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Joe Pleshek, Brand Protection Market Manager at Appleton Security Products

Joe Pleshek is the Brand Protection Market Manager at Appleton Security Products. His role is to develop innovative product and service solutions to help companies protect their brands from counterfeiting, diversion and piracy. Prior to joining Appleton, Joe worked in 3M's Printing and Publishing division.

Joe has held several positions in business development, channel management, marketing and brand management. He has a Bachelor of Science degree in Printing Management from the University of Wisconsin-Stout, and an MBA from the University of St Thomas. .

spacer
Joe Pleshek
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients

Based in Szczecin, this facility extends Nemera’s manufacturing capabilities and will bring more drug delivery device solutions to patients. Following the dynamic growth of the drug delivery devices market, as a world leader, Nemera is thrilled to extend its manufacturing capabilities in Poland.
More info >>

White Papers

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement